Brown fat as a therapy for obesity and diabetes

Haslam, 2006, Obesity, Lancet, 366, 1197, 10.1016/S0140-6736(05)67483-1

Rosen, 2006, Adipocytes as regulators of energy balance and glucose homeostasis, Nature, 444, 847, 10.1038/nature05483

Puri, 2008, RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27, Acta Physiol (Oxf), 192, 103, 10.1111/j.1748-1716.2007.01786.x

Gesta, 2007, Developmental origin of fat: tracking obesity to its source, Cell, 131, 242, 10.1016/j.cell.2007.10.004

Arkan, 2005, IKK-beta links inflammation to obesity-induced insulin resistance, Nat Med, 11, 191, 10.1038/nm1185

Almind, 2007, Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice, Proc Natl Acad Sci U S A, 104, 2366, 10.1073/pnas.0610416104

Xue, 2007, Genetic variability affects the development of brown adipocytes in white fat but not in interscapular brown fat, J Lipid Res, 48, 41, 10.1194/jlr.M600287-JLR200

Cinti, 2005, The adipose organ, Prostaglandins leukot essent fatty acids, 73, 9, 10.1016/j.plefa.2005.04.010

Ghorbani, 1997, Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist, Biochem Pharmacol, 54, 121, 10.1016/S0006-2952(97)00162-7

Guerra, 1998, Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity, J Clin Invest, 102, 412, 10.1172/JCI3155

Lowell, 1993, Development of obesity in transgenic mice after genetic ablation of brown adipose tissue, Nature, 366, 740, 10.1038/366740a0

Foster, 1979, Tissue distribution of cold-induced thermogenesis in conscious warm or cold-acclimated rats reevaluated from changes in tissue blood flow: the dominant role of brown adipose tissue in the replacement of shivering by nonshivering thermogenesis, Can J Physiol Pharmacol, 57, 257, 10.1139/y79-039

Rothwell, 1983, Luxuskonsumption, diet-induced thermogenesis and brown fat: the case in favour, Clin Sci (Lond), 64, 19, 10.1042/cs0640019

Golozoubova, 2001, Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold, FASEB J, 15, 2048, 10.1096/fj.00-0536fje

Huttunen, 1981, The occurrence of brown adipose tissue in outdoor workers, Eur J Appl Physiol Occup Physiol, 46, 339, 10.1007/BF00422121

English, 1973, Association of pheochromocytomas with brown fat tumors, Radiology, 107, 279, 10.1148/107.2.279

Nedergaard, 2007, Unexpected evidence for active brown adipose tissue in adult humans, Am J Physiol Endocrinol Metab, 293, E444, 10.1152/ajpendo.00691.2006

Furlong, 2001, The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases, Am J Surg Pathol, 25, 809, 10.1097/00000478-200106000-00014

Heaton, 1972, The distribution of brown adipose tissue in the human, J Anat, 112, 35

Astrup, 1986, Thermogenesis in human brown adipose tissue and skeletal muscle induced by sympathomimetic stimulation, Acta Endocrinol Suppl (Copenh), 278, 1

Weyer, 1998, Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans, Diabetes, 47, 1555, 10.2337/diabetes.47.10.1555

Larsen, 2002, Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men, Am J Clin Nutr, 76, 780, 10.1093/ajcn/76.4.780

Cunningham, 1985, The characterization and energetic potential of brown adipose tissue in man, Clin Sci (Lond), 69, 343, 10.1042/cs0690343

Schoder, 2004, PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies, J Nucl Med, 45, 72S

Hany, 2002, Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region, Eur J Nucl Med Mol Imaging, 29, 1393, 10.1007/s00259-002-0902-6

Cohade, 2003, Uptake in supraclavicular area fat (“USA-Fat”): description on 18F-FDG PET/CT, J Nucl Med, 44, 170

Cypess, 2009, Identification and importance of brown adipose tissue in adult humans, N Engl J Med, 360, 1509, 10.1056/NEJMoa0810780

Marken Lichtenbelt, 2009, Cold-activated brown adipose tissue in healthy men, N Engl J Med, 360, 1500, 10.1056/NEJMoa0808718

Virtanen, 2009, Functional brown adipose tissue in healthy adults, N Engl J Med, 360, 1518, 10.1056/NEJMoa0808949

Zingaretti, 2009, The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue, FASEB J, 23, 3113, 10.1096/fj.09-133546

Saito, 2009, High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity, Diabetes, 58, 1526, 10.2337/db09-0530

Celi, 2009, Brown adipose tissue: when it pays to be inefficient, N Engl J Med, 360, 1553, 10.1056/NEJMe0900466

Timmons, 2007, Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages, Proc Natl Acad Sci U S A, 104, 4401, 10.1073/pnas.0610615104

Seale, 2008, PRDM16 controls a brown fat/skeletal muscle switch, Nature, 454, 961, 10.1038/nature07182

Kopecky, 1995, Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity, J Clin Invest, 96, 2914, 10.1172/JCI118363

Leonardsson, 2004, Nuclear receptor corepressor RIP140 regulates fat accumulation, Proc Natl Acad Sci U S A, 101, 8437, 10.1073/pnas.0401013101

Hansen, 2004, Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation, Proc Natl Acad Sci U S A, 101, 4112, 10.1073/pnas.0301964101

Scime, 2005, Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha, Cell Metab, 2, 283, 10.1016/j.cmet.2005.10.002

Tseng, 2005, Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin, Nat Cell Biol, 7, 601, 10.1038/ncb1259

Cowherd, 1999, Molecular regulation of adipocyte differentiation, PMID, 10, 3

Seale, 2007, Transcriptional control of brown fat determination by PRDM16, Cell Metab, 6, 38, 10.1016/j.cmet.2007.06.001

Kajimura, 2008, Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex, Genes Dev, 22, 1397, 10.1101/gad.1666108

Kajimura, 2009, Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex, Nature, 460, 1154, 10.1038/nature08262

Cannon, 2004, Brown adipose tissue: function and physiological significance, Physiol Rev, 84, 277, 10.1152/physrev.00015.2003

Schulz, 2009, Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism, Cytokine Growth Factor Rev, 20, 523, 10.1016/j.cytogfr.2009.10.019

Tseng, 2008, New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure, Nature, 454, 1000, 10.1038/nature07221

Shen, 2009, Deficiency of growth differentiation factor 3 protects against diet-induced obesity by selectively acting on white adipose, Mol Endocrinol, 23, 113, 10.1210/me.2007-0322

Konishi, 2000, Fibroblast growth factor-16 is a growth factor for embryonic brown adipocytes, J Biol Chem, 275, 12119, 10.1074/jbc.275.16.12119

Tomlinson, 2002, Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity, Endocrinology, 143, 1741, 10.1210/endo.143.5.8850

Kharitonenkov, 2005, FGF-21 as a novel metabolic regulator, J Clin Invest, 115, 1627, 10.1172/JCI23606

Mori, 2000, Disruption of klotho gene causes an abnormal energy homeostasis in mice, Biochem Biophys Res Commun, 278, 665, 10.1006/bbrc.2000.3864

Kaplan, 2005, Pharmacological therapies for obesity, Gastroenterol Clin North Am, 34, 91, 10.1016/j.gtc.2004.12.002

Melnikova, 2006, Antiobesity therapies, Nat Rev Drug Discov, 5, 369, 10.1038/nrd2037

Shekelle, 2003, Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis, JAMA, 289, 1537, 10.1001/jama.289.12.1537

Arch, 2008, The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists, Naunyn Schmiedebergs Arch Pharmacol, 378, 225, 10.1007/s00210-008-0271-1

Tiwari, 2009, TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders, Drug Discov Today, 14, 523, 10.1016/j.drudis.2009.02.005

Thomas, 2009, TGR5-mediated bile acid sensing controls glucose homeostasis, Cell Metab, 10, 167, 10.1016/j.cmet.2009.08.001

Kendall, 2006, Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a double-blind, randomized, pioglitazone-comparative study, Diabetes Care, 29, 1016, 10.2337/dc05-1146

Henry, 2009, Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study, Lancet, 374, 126, 10.1016/S0140-6736(09)60870-9

Yamamoto, 2007, Sirtuin functions in health and disease, Mol Endocrinol, 21, 1745, 10.1210/me.2007-0079

Wang, 2003, Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity, Cell, 113, 159, 10.1016/S0092-8674(03)00269-1

Harper, 2008, The efficiency of cellular energy transduction and its implications for obesity, Annu Rev Nutr, 28, 13, 10.1146/annurev.nutr.28.061807.155357

Tam, 2009, A mathematical model of murine metabolic regulation by leptin: energy balance and defense of a stable body weight, Cell Metab, 9, 52, 10.1016/j.cmet.2008.11.005

Nelson, 2006, Central nervous system biogenic amine targets for control of appetite and energy expenditure, Endocrine, 29, 49, 10.1385/ENDO:29:1:49

Baba, 2007, Effect of nicotine and ephedrine on the accumulation of 18F-FDG in brown adipose tissue, J Nucl Med, 48, 981, 10.2967/jnumed.106.039065

Clapham, 2007, Thermogenic and metabolic antiobesity drugs: rationale and opportunities, Diabetes Obes Metab, 9, 259, 10.1111/j.1463-1326.2006.00608.x

van Baak, 2002, Acute effect of L-796568, a novel beta 3-adrenergic receptor agonist, on energy expenditure in obese men, Clin Pharmacol Ther, 71, 272, 10.1067/mcp.2002.122527

Tobin, 2006, Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease, Drug Discov Today, 11, 405, 10.1016/j.drudis.2006.03.016

Li, 2004, Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease, Curr Opin Nephrol Hypertens, 13, 417, 10.1097/01.mnh.0000133974.24935.fe

Wang, 2003, Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy, Kidney Int, 63, 2037, 10.1046/j.1523-1755.2003.00035.x

Badman, 2007, Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states, Cell Metab, 5, 426, 10.1016/j.cmet.2007.05.002

Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 92, 829, 10.1016/S0092-8674(00)81410-5

Vernochet, 2009, C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists, Mol Cell Biol, 29, 4714, 10.1128/MCB.01899-08